Privately held U.S. Renal Care raised $328 million in new capital to accelerate the company’s growth and expansion plans. The source of the fresh funding was not disclosed.
The new capital will be invested in programs focused on innovation and continued delivery of kidney care, as well as the continued professional development of the company’s care teams. Currently, 22% of all practicing nephrologists in the United States have privileges and care for patients in USRC clinics and a majority of these nephrologists are also joint venture partners with the company in dialysis clinics and/or value-based care programs.
USRC’s legal advisor is Kirkland & Ellis, and its financial advisor is PJT Partners. Read more.
